Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-01

Clinical Trial Update: Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated L-PRF as a slow-release antibiotic device for moderate periodontitis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-PRF

Snippet

Sponsor: Yasmeen Khaled | Conditions: Periodontitis | Phase 2, Phase 3 | Status: COMPLETED